2279 |
DEB in In-stent Restenosis |
Seung-Woon Rha |
May. 12. 14 |
2278 |
DEB in De Novo |
Donghoon Choi |
May. 12. 14 |
2277 |
Are All DEB Same? DEB from Technological Viewpoint |
Robert J. Melder |
May. 12. 14 |
2276 |
Real World Practice Sharing (Promus Premier) |
Huay Cheem Tan |
May. 09. 14 |
2275 |
PLATINUM Clinical Data Overview |
Bong-Ki Lee |
May. 09. 14 |
2274 |
Evolution of DES and Its Future |
Dominic Allocco |
May. 09. 14 |
2273 |
A Holistic Method for Considering the Diabetic Patient - Early Cases from the BIOFLOW Diabetic Registry |
Upendra Kaul |
May. 09. 14 |
2272 |
CYP2C19 Genetic Profiling for Thienopyridine Management After Primary Percutaneous Coronary Intervention |
Bernard R. Chevalier |
May. 09. 14 |
2271 |
How Will Treatment Paradigms Change in a Drug-eluting World? |
Massimiliano Fusaro |
May. 09. 14 |
2270 |
Severe Calcification: Technical Challenges and Clinical Implications |
Krishna Rocha-Singh |
May. 09. 14 |